<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04504383</url>
  </required_header>
  <id_info>
    <org_study_id>PN-943-03</org_study_id>
    <nct_id>NCT04504383</nct_id>
  </id_info>
  <brief_title>PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)</brief_title>
  <official_title>A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Oral PN-943 in Subjects With Moderate to Severe Active Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Protagonist Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Protagonist Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the safety, tolerability, and clinical efficacy of&#xD;
      PN-943 450 mg twice daily [BID] and PN-943 150 mg BID, compared with placebo BID, in subjects&#xD;
      with moderate to severe active Ulcerative Colitis (UC).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study consists of a 12-week double-blind, placebo-controlled treatment period.&#xD;
      Participants will be randomized in a 1:1:1 ratio to PN-943 450 mg BID, PN-943 150 mg BID, or&#xD;
      matching placebo BID.&#xD;
&#xD;
      Participants who successfully complete the double-blind period may be eligible for an&#xD;
      extended treatment period of 40 weeks duration.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>12-week randomized, double-blind, placebo-controlled, parallel design study in patients with moderate to severe active UC. It will be followed by 40 weeks of Extended Active Treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of subjects achieving clinical remission at Week 12 compared to placebo.</measure>
    <time_frame>Week 12</time_frame>
    <description>Clinical remission is determined using the Adapted Mayo score (sum of 3 subscores from the Mayo score):&#xD;
Stool frequency subscore (SFS)&#xD;
Rectal bleeding subscore (RBS)&#xD;
Endoscopic subscore (ESS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison between PN-943 high-dose and low-dose individually to placebo.</measure>
    <time_frame>Week 12</time_frame>
    <description>Proportion of subjects with endoscopic improvement.&#xD;
Proportion of subjects achieving endoscopic remission.&#xD;
Proportion of subjects with histological improvement.&#xD;
Proportion of subjects achieving histological remission.&#xD;
Proportion of subjects with mucosal healing.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Proportion of subjects achieving clinical remission at Week 52.</measure>
    <time_frame>Week 52</time_frame>
    <description>Clinical remission is determined using the Adapted Mayo score (sum of 3 subscores from the Mayo score):&#xD;
Stool frequency subscore (SFS)&#xD;
Rectal bleeding subscore (RBS)&#xD;
Endoscopic subscore (ESS)</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Ulcerative Colitis Chronic Moderate</condition>
  <condition>Ulcerative Colitis Chronic Severe</condition>
  <arm_group>
    <arm_group_label>PN-943 450 mg BID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral administration of PN-943 450 mg BID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PN-943 150 mg BID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral administration of PN-943 150 mg BID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo BID</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral administration of matching placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PN-943</intervention_name>
    <description>Administered by the oral route BID for the duration of the study.</description>
    <arm_group_label>PN-943 150 mg BID</arm_group_label>
    <arm_group_label>PN-943 450 mg BID</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered by the oral route BID for 12 weeks.</description>
    <arm_group_label>Placebo BID</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          1. Male and female subjects age 18 (or the minimum country specific age of consent if&#xD;
             &gt;18) to 75 years.&#xD;
&#xD;
          2. Subject understands the study procedures and agrees to participate in the study by&#xD;
             giving written informed consent.&#xD;
&#xD;
          3. Diagnosis of UC supported by appropriate documentation of biopsy results consistent&#xD;
             with UC.&#xD;
&#xD;
          4. Moderate to severe active UC.&#xD;
&#xD;
          5. Demonstrated inadequate response, loss of response, or intolerance of at least 1 of&#xD;
             oral aminosalicylates (5-ASAs), corticosteroids, immunomodulators, or a biologic&#xD;
             (excluding vedolizumab).&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          1. Subject with a current diagnosis of Crohn's disease (CD), indeterminate colitis (IC),&#xD;
             microscopic colitis, ischemic colitis, radiation colitis.&#xD;
&#xD;
          2. History of colonic dysplasia other than completely removed low-grade dysplastic&#xD;
             lesion.&#xD;
&#xD;
          3. History of active bacterial, viral, fungal or mycobacterial infection requiring&#xD;
             hospitalization or IV antibiotic/anti-infective treatment within 4 weeks of screening&#xD;
             or oral antibiotics/anti-infectives within 2 weeks of screening.&#xD;
&#xD;
          4. Prior treatment with vedolizumab, natalizumab, or any agent targeting the α4β7 or β1&#xD;
             integrin or planned during the study.&#xD;
&#xD;
          5. Positive stool test for C. difficile.&#xD;
&#xD;
          6. Chronic recurrent or serious infection.&#xD;
&#xD;
          7. Known primary or secondary immunodeficiency.&#xD;
&#xD;
          8. Pregnant or lactating female or considering becoming pregnant during the study or&#xD;
             within 30 days after the last dose of study medication.&#xD;
&#xD;
          9. History of any major neurological disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Study Director</last_name>
    <phone>1-888-899-1543</phone>
    <email>ptgxclintrials@ptgx-inc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Murrieta</city>
        <state>California</state>
        <zip>92563</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33175</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Saint Augustine</city>
        <state>Florida</state>
        <zip>32086</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Wesley Chapel</city>
        <state>Florida</state>
        <zip>33544</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Glen Burnie</city>
        <state>Maryland</state>
        <zip>21061</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Chesterfield</city>
        <state>Michigan</state>
        <zip>48047</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>North Massapequa</city>
        <state>New York</state>
        <zip>11758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Norman</city>
        <state>Oklahoma</state>
        <zip>73071</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78742</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational site</name>
      <address>
        <city>Garland</city>
        <state>Texas</state>
        <zip>75044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Pasadena</city>
        <state>Texas</state>
        <zip>77505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Spring</city>
        <state>Texas</state>
        <zip>77388</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational site</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1303</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1Y 4N7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6K 2K5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>West Vancouver</city>
        <state>British Columbia</state>
        <zip>V7T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>North Bay</city>
        <state>Ontario</state>
        <zip>P1B 2H3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 3A9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Vaughan</city>
        <state>Ontario</state>
        <zip>L4L 4Y7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0141</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0144</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0160</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0186</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>14163</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>H-1033</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Debrecen</city>
        <zip>4025</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Székesfehérvár</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Castellana Grotte</city>
        <zip>70013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Negrar</city>
        <zip>37024</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Roma</city>
        <zip>00152</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Busan</city>
        <zip>48079</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Busan</city>
        <zip>49201</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Daegu</city>
        <zip>42415</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Daegu</city>
        <zip>42601</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Daejeon</city>
        <zip>34943</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational site</name>
      <address>
        <city>Seoul</city>
        <zip>06973</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Poznań</city>
        <state>Wielkopolskie</state>
        <zip>60-848</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-079</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85794</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Czestochowa</city>
        <zip>42-200</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Czestochowa</city>
        <zip>42217</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Katowice</city>
        <zip>40-748</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kraków</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Ksawerów</city>
        <zip>95-054</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Lublin</city>
        <zip>20-582</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Nowy Targ</city>
        <zip>34-400</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Piotrków Trybunalski</city>
        <zip>97-300</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Poznań</city>
        <zip>60-529</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Poznań</city>
        <zip>61-441</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Rzeszów</city>
        <zip>35-326</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Sopot</city>
        <zip>81-756</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Swidnica</city>
        <zip>58-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Toruń</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tychy</city>
        <zip>43-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Warsaw</city>
        <zip>00-635</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Warsaw</city>
        <zip>00-728</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>00-332</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Wrocław</city>
        <zip>50449</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Wrocław</city>
        <zip>51-162</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Wrocław</city>
        <zip>51-685</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Wrocław</city>
        <zip>52210</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Włocławek</city>
        <zip>87-800</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Łódź</city>
        <zip>90-349</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Łódź</city>
        <zip>90-644</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454076</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>105554</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Perm</city>
        <zip>614068</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Pyatigorsk</city>
        <zip>357500</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196143</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197089</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Samara</city>
        <zip>443029</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Saratow</city>
        <zip>410053</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Stavropol'</city>
        <zip>355000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <zip>634063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Tyumen</city>
        <zip>625026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Ivano-Frankivs'k</city>
        <zip>76018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kherson</city>
        <zip>73000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>01030</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>01103</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>04073</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Lviv</city>
        <zip>79007</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Protagonist Investigational Site</name>
      <address>
        <city>Zhytomyr</city>
        <zip>10003</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <phone>888-899-1543</phone>
      <email>ptgxclintrials@ptgx-inc.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Georgia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 5, 2020</study_first_submitted>
  <study_first_submitted_qc>August 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2020</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inflammatory Bowel Disease (IBD)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

